• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板激活因子受体拮抗剂WEB 2086在体外对牛体内PAF诱导的血小板聚集的抑制作用。

Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.

作者信息

da Silva M B, Herion F, Raskinet R, David J L, Gustin P, Dessy C, Lekeux P

机构信息

Laboratory for Functional Investigation, Faculty of Veterinary Medicine, University of Liège, Belgium.

出版信息

Zentralbl Veterinarmed A. 1996 Sep;43(7):399-413. doi: 10.1111/j.1439-0442.1996.tb00468.x.

DOI:10.1111/j.1439-0442.1996.tb00468.x
PMID:8921726
Abstract

The sensitivity of bovine platelet aggregation in response to PAF stimulation and the ability of WEB 2086 (a thieno-triazolodiazepine) to inhibit response to PAF-induced platelet aggregation were investigated in the blood from five healthy male Belgian Blue calves. The recorded response to PAF showed a plateau which was dependent on the PAF concentration. Platelet aggregation induced by PAF consists of two mechanisms: reversible and irreversible aggregations which are accompanied by the release of platelet granule contents. Reversible aggregation occurred above (2 . 10(-9) mol/l) PAF, and irreversible aggregation occurred above (2 . 10(-7) mol/l) PAF. Addition of WEB 2086 to bovine platelets in vitro induced a rightward shift in the dose-response curve to PAF. WEB 2086 inhibited PAF-induced aggregation in a competitive reversible manner (pA2 = 7.61). The results of our study show that PAF induces platelet aggregation in platelet-rich plasma (PRP) and that addition of WEB 2086 to bovine platelets in vitro inhibits PAF-induced Platelet Aggregation.

摘要

研究了5头健康雄性比利时蓝牛犊血液中牛血小板对血小板活化因子(PAF)刺激的聚集敏感性以及WEB 2086(一种噻吩并三唑二氮杂卓)抑制PAF诱导的血小板聚集反应的能力。记录到的对PAF的反应呈现出一个依赖于PAF浓度的平台期。PAF诱导的血小板聚集由两种机制组成:可逆性聚集和不可逆性聚集,且伴有血小板颗粒内容物的释放。可逆性聚集在PAF浓度高于(2×10⁻⁹摩尔/升)时发生,不可逆性聚集在PAF浓度高于(2×10⁻⁷摩尔/升)时发生。在体外将WEB 2086添加到牛血小板中会导致对PAF的剂量反应曲线向右移动。WEB 2086以竞争性可逆方式抑制PAF诱导的聚集(pA2 = 7.61)。我们的研究结果表明,PAF在富含血小板血浆(PRP)中诱导血小板聚集,并且在体外将WEB 2086添加到牛血小板中可抑制PAF诱导的血小板聚集。

相似文献

1
Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.血小板激活因子受体拮抗剂WEB 2086在体外对牛体内PAF诱导的血小板聚集的抑制作用。
Zentralbl Veterinarmed A. 1996 Sep;43(7):399-413. doi: 10.1111/j.1439-0442.1996.tb00468.x.
2
Combined effect of Web 2086 (Paf antagonist) and ketoprofen (Nsaid) on Paf-induced ex vivo platelet aggregation in bovine.Web 2086(血小板活化因子拮抗剂)与酮洛芬(非甾体抗炎药)对牛体内血小板活化因子诱导的体外血小板聚集的联合作用
Zentralbl Veterinarmed A. 1997 Apr;44(2):65-71. doi: 10.1111/j.1439-0442.1997.tb01087.x.
3
Interaction of the Paf antagonist WEB 2086 and its hetrazepine analogues with human platelets and endothelial cells.血小板活化因子拮抗剂WEB 2086及其杂氮䓬类似物与人类血小板和内皮细胞的相互作用。
Br J Pharmacol. 1989 Oct;98(2):653-61. doi: 10.1111/j.1476-5381.1989.tb12640.x.
4
Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
Equine Vet J. 1992 May;24(3):203-7. doi: 10.1111/j.2042-3306.1992.tb02815.x.
5
In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation.强效血小板活化因子(PAF)受体拮抗剂SR 27417对PAF诱导的牛血小板聚集的体外抑制作用。
Vet Res. 2000 Mar-Apr;31(2):267-72. doi: 10.1051/vetres:2000115.
6
Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets.血小板的长期聚集需要PAF分子与其受体持续结合。
Am J Physiol. 1998 Jan;274(1):C47-57. doi: 10.1152/ajpcell.1998.274.1.C47.
7
Pharmacological actions of Y-24180, a new specific antagonist of platelet activating factor (PAF): II. Interactions with PAF and benzodiazepine receptors.血小板活化因子(PAF)新型特异性拮抗剂Y-24180的药理作用:II. 与PAF及苯二氮䓬受体的相互作用
Prostaglandins. 1990 Dec;40(6):571-83. doi: 10.1016/0090-6980(90)90002-d.
8
Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood.抗血小板药物对人全血中血小板活化因子(PAF)诱导的血小板聚集的影响。
Prostaglandins. 1991 Oct;42(4):337-42. doi: 10.1016/0090-6980(91)90082-q.
9
Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood.血小板活化因子(PAF)受体拮抗剂可抑制花生四烯酸诱导的兔全血血小板聚集。
Lipids. 1991 Dec;26(12):1189-92. doi: 10.1007/BF02536529.
10
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Vet Res Commun. 1997 Oct;21(7):521-31. doi: 10.1023/a:1005950622207.

引用本文的文献

1
Cigarette smoke-induced urothelial cell damage: potential role of platelet-activating factor.香烟烟雾诱导的尿路上皮细胞损伤:血小板活化因子的潜在作用。
Physiol Rep. 2017 Mar;5(5). doi: 10.14814/phy2.13177.
2
Protective effects of WEB 2086 (PAF antagonist) and ketoprofen (NSAID) on PAF-induced changes in the morphological ultrastructure of blood platelets in calves.WEB 2086(血小板活化因子拮抗剂)和酮洛芬(非甾体抗炎药)对血小板活化因子诱导的犊牛血小板形态超微结构变化的保护作用。
Vet Res Commun. 1998 Jun;22(4):273-91. doi: 10.1023/a:1006007802126.
3
The effect of intravenous administration of WEB 2086 on PAF-induced platelet aggregation in healthy Friesian calves.
Vet Res Commun. 1997 Oct;21(7):521-31. doi: 10.1023/a:1005950622207.